377: Melodrama at the FDA and the Pfizer-Novo bidding war
06 Nov 2025
31m
STAT · Science
The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Episodes
376: BridgeBio’s great week and Moderna’s unraveling
30 Oct 2025
38m
375: Startups push the FDA and biotech booms in North Carolina
23 Oct 2025
28m
374: Veteran biotech executive Clive Meanwell on drug pricing and the obesity market
16 Oct 2025
34m
373: Party in biotech land and AstraZeneca’s miscalculation
09 Oct 2025
45m
372: A pharma C-suite shakeup and Trump's deal with Pfizer
02 Oct 2025
28m
371: A gene therapy success in Huntington's and Trump's autism announcement
25 Sep 2025
42m
370: Pharma sours on the U.K., plus biotech M&A's quiet roll
18 Sep 2025
37m
369: Trump, Chinese biotech, and an industry career reshaped by illness
11 Sep 2025
35m
368: New stakes in the vaccine dispute and a boost for biotech
04 Sep 2025
26m
367: The ouster of CDC's director, biotech venture firm rankings
28 Aug 2025
27m
366: Viking’s obesity flop, ‘pharma to table’ drug sales
21 Aug 2025
24m
365: Vinay Prasad’s return, animal testing alternatives, and mRNA upended
14 Aug 2025
27m
364: Closing a zombie biotech, and Lilly's disappointing obesity readout
07 Aug 2025
36m
363: What Vinay Prasad’s ouster means for biotech and the FDA
31 Jul 2025
43m
362: A mother’s perspective on Sarepta’s gene therapy halt
24 Jul 2025
35m
361: Inside an FDA drug rejection, and layoffs at Sarepta
17 Jul 2025
42m
360: NIH grant cuts, FDA transparency questions and biotech M&A
10 Jul 2025
24m
359: Vaccine policy frays, CDC nominee in the hot seat, & obesity drug side effects
26 Jun 2025
33m
358: FDA's gene therapy turmoil, and an alternative model for funding research
19 Jun 2025
29m
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.